Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. Art of Medicine May 2023 A Completely Normal Conversation With a Box Beck Regan Health professional students often attend lectures equating resiliency with self-care. AMA J Ethics. 2023;25(5):E378-379. doi: 10.1001/amajethics.2023.378. Case and Commentary Jul 2023 Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy Madeline Ward, PhD Healthist views about body shape and weight are oppressive and lead to pernicious harms, especially to members of vulnerable groups. AMA J Ethics. 2023;25(7):E472-477. doi: 10.1001/amajethics.2023.472. Case and Commentary Jul 2023 Should Pharmaceuticals Be Used as Weight Loss Interventions for Adolescents Classified as Obese by BMI? Astrid Floegel-Shetty, MA Weight loss is not a safe, effective, or permanent method of health promotion, and pharmacotherapeutical approaches pose specific risks to adolescents. AMA J Ethics. 2023;25(7):E478-495. doi: 10.1001/amajethics.2023.478. Letter to the Editor Sep 2006 Commercial Labs Offer High Quality Services Herman Hurwitz, MD Virtual Mentor. 2006;8(9):C1-C3. doi: 10.1001/virtualmentor.2006.8.9.corr1-0609. Case and Commentary Aug 2006 Dermatology Lab Referrals: Cash Cow or Ethical Trap? Jane M. Grant-Kels, MD and Barry D. Kels, MD, JD Virtual Mentor. 2006;8(8):499-502. doi: 10.1001/virtualmentor.2006.8.8.ccas2-0608. Case and Commentary Aug 2006 Dispensing Cosmeceuticals from the Office Michael H. Gold, MD Virtual Mentor. 2006;8(8):503-508. doi: 10.1001/virtualmentor.2006.8.8.ccas1-0608. Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608. Case and Commentary May 2016 Consequences for Patients and Their Loved Ones When Physicians Refuse to Participate in Ethics Consultation Processes David S. Seres, MD, ScM While some physicians try to avoid ethics consultations, their participation can be essential for good patient care. AMA J Ethics. 2016;18(5):493-498. doi: 10.1001/journalofethics.2016.18.5.ecas3-1605. Podcast Jul 2023 Author Interview: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy” Dr Madeline Ward joins Ethics Talk to discuss her article: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy." Pagination Current page 1 Page 2 Next page Next › Last page Last »
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Art of Medicine May 2023 A Completely Normal Conversation With a Box Beck Regan Health professional students often attend lectures equating resiliency with self-care. AMA J Ethics. 2023;25(5):E378-379. doi: 10.1001/amajethics.2023.378.
Case and Commentary Jul 2023 Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy Madeline Ward, PhD Healthist views about body shape and weight are oppressive and lead to pernicious harms, especially to members of vulnerable groups. AMA J Ethics. 2023;25(7):E472-477. doi: 10.1001/amajethics.2023.472.
Case and Commentary Jul 2023 Should Pharmaceuticals Be Used as Weight Loss Interventions for Adolescents Classified as Obese by BMI? Astrid Floegel-Shetty, MA Weight loss is not a safe, effective, or permanent method of health promotion, and pharmacotherapeutical approaches pose specific risks to adolescents. AMA J Ethics. 2023;25(7):E478-495. doi: 10.1001/amajethics.2023.478.
Letter to the Editor Sep 2006 Commercial Labs Offer High Quality Services Herman Hurwitz, MD Virtual Mentor. 2006;8(9):C1-C3. doi: 10.1001/virtualmentor.2006.8.9.corr1-0609.
Case and Commentary Aug 2006 Dermatology Lab Referrals: Cash Cow or Ethical Trap? Jane M. Grant-Kels, MD and Barry D. Kels, MD, JD Virtual Mentor. 2006;8(8):499-502. doi: 10.1001/virtualmentor.2006.8.8.ccas2-0608.
Case and Commentary Aug 2006 Dispensing Cosmeceuticals from the Office Michael H. Gold, MD Virtual Mentor. 2006;8(8):503-508. doi: 10.1001/virtualmentor.2006.8.8.ccas1-0608.
Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608.
Case and Commentary May 2016 Consequences for Patients and Their Loved Ones When Physicians Refuse to Participate in Ethics Consultation Processes David S. Seres, MD, ScM While some physicians try to avoid ethics consultations, their participation can be essential for good patient care. AMA J Ethics. 2016;18(5):493-498. doi: 10.1001/journalofethics.2016.18.5.ecas3-1605.
Podcast Jul 2023 Author Interview: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy” Dr Madeline Ward joins Ethics Talk to discuss her article: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy."